Boston Scientific To Pay Up To $375M For Atritech

Law360, New York (January 19, 2011, 1:38 PM EST) -- Boston Scientific Corp. said Wednesday it planned to shell out $100 million up front and up to $275 million in additional payments to acquire medical device maker Atritech Inc., potentially expanding its footprint in the market for less-invasive cardiovascular devices.

Natick, Mass.-based Boston Scientific said the additional payments would be made upon achievement of specified regulatory and revenue-based milestones through 2015, while the upfront payment would be funded with cash on hand.

Boston Scientific said it expected the deal to slash about 1 cent to 2...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.